Jun Liu

Dr. Jun Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in International Journal of Biological Sciences
Verified
Journal Article
Open access
JLJun Liu
Jun Liu
QLQingqing Li
Qingqing Li
XLXiaoxin Li
Xiaoxin Li
ZQZhenzhen Qiu
Zhenzhen Qiu
ALAndrew Li
Andrew Li
HLHongwei Li
Hongwei Li
Clinical evidence suggests that there exists a strong correlation between Zika virus (ZIKV) infection and abnormal development of the nervous system. However, the underlying mechanisms remain to be elusive. In this study, recombinant lentiviral vectors coding for ZIKV structural proteins and truncations (prM-Env, M-Env and Env) were transduced into PC12 cells. Envelope (Env) overexpression induced significant inhibition of proliferation and triggered G2/M cell cycle arrest and apoptosis in PC12 cells. Flow cytometry and western blot analysis showed that the apoptosis was associated with up-regulation of both p53 and p21Cip1/Waf1 and down-regulation of cyclin B1. Presence of aberrant nuclei clusters were confirmed by immunofluorescence staining analysis. The data indicate that overexpression of prM-Env, M-Env or Env led to apoptosis via an intrinsic cell death signaling pathway that is dependent on the activation of caspase-9 and caspase-3 and accompanied by an increased ratio of Bax to Bcl-2 in transduced PC12 cells. In summary, our results suggest that ZIKV Env protein causes apoptosis in PC12 cells via an intrinsic cell death signaling pathway, which may contribute to ZIKV-induced abnormal development of the nervous system.

1 November 2021 in Journal of Dermatological Science
Verified
Journal Article
Closed access
JLJun Liu
Jun Liu
YZYadan Zhong
Yadan Zhong
HLHuiting Liu
Huiting Liu
HYHuan Yang
Huan Yang
PLPing Lu
Ping Lu
BYBin Yang
Bin Yang

7 June 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JLJun Liu
Jun Liu
XZXinhui Zhao
Xinhui Zhao
KWKe Wang
Ke Wang
XZXiang Zhang
Xiang Zhang
YYYanping Yu
Yanping Yu
PLPeng Li
Peng Li
Solute carrier family 35 member B4 (SLC35B4), a nucleotide sugar transporter, is capable of transporting UDP-xylose and UDP-GlcNAc from the cytoplasm to the lumen of the endoplasmic reticulum and Golgi. SLC35B4 has a pivotal role in glycosylation of biological macromolecules. However, its functional roles and regulatory mechanisms in malignant diseases remain unknown. Here, using the cDNA arrays, promoter reporter assays, and chromatin immunoprecipitation assays, we demonstrated that SLC35B4 is directly transactivated by YAP1–TEADs complex in gastric cancer (GC) cells. CCK-8, plate colony formation and soft agar assays revealed that SLC35B4 is essential for survival and proliferation in GC cells and nude mice models. SLC35B4 expression is markedly higher in GC tissues compared with control noncancerous tissues. Immunohistochemistry revealed that SLC35B4 expression is positively correlated with YAP1 expression in human GC tissues, and this correlation is also confirmed in the GC TCGA data set. GC patients with high levels of SLC35B4 expression have poorer prognosis than those with low levels of SLC35B4 expression. Collectively, our findings defined SLC35B4 as an important downstream oncogenic target of YAP1, suggesting that dysregulated signaling of a novel YAP1/SLC35B4 axis promotes GC development and progression, and this axis could be a potential candidate for prognosis and therapeutics in GC.

27 January 2021 in Protein & Cell
Verified
Journal Article
Open access
PDF file
JLJun Liu
Jun Liu
JCJunchen Chen
Junchen Chen
YZYadan Zhong
Yadan Zhong
XYXiaoling Yu
Xiaoling Yu
PLPing Lu
Ping Lu
ZRZhili Rong
Zhili Rong

28 January 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JGJing-Jing Gu
Jing-Jing Gu
CDCheng-Cheng Deng
Cheng-Cheng Deng
QFQing-Lan Feng
Qing-Lan Feng
JLJun Liu
Jun Liu
DZDing-Heng Zhu
Ding-Heng Zhu
BYBin Yang
Bin Yang

1 March 2016 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
JLJun Liu
Jun Liu
SXShuilin Xie
Shuilin Xie
YWYukun Wu
Yukun Wu
MXMeinian Xu
Meinian Xu
CAChunping Ao
Chunping Ao
MLming Li
ming Li
The present study aimed to determine whether actinomycin X2 (AX2) intercepted the mTOR/PTEN/PI3K/Akt signaling pathway to inhibit human prostate cancer cells (PC-3) in vitro. The effects of AX2 on mTOR, PTEN, PI3K, and Akt at the protein level and mRNA were determined by western blotting and real-time reverse transcription-PCR (RT-PCR), respectively. Concurrently, the effects of AX2 on expression levels of MiRNA144 and MiRNA126 in PC-3 were measured by real-time RT-PCR. The association of MiRNA144 with 3'-UTR of mTOR was identified using the Dual-Luciferase Reporter Gene System. The direct effect of MIRNA144 on the mTOR/PTEN/PI3K/Akt pathway was determined by real-time RT-PCR and western blotting. Apoptosis of PC-3 cells induced by AX2 was determined by MTT and flow cytometry. The results indicated that mTOR/PTEN/PI3K/Akt were decreased and PTEN was increased by AX (1, 10 µmol/l) at protein and mRNA levels in a dose-dependent manner. MiRNA144 was decreased, whereas MiRNA126 was increased by AX2. MiRNA144 associated with 3'-UTR of mTOR was corroborated. Overexpression of MiRNA144 decreased mTOR, but did not affect PTEN, PI3K, or Akt. The proliferation rates of AX2 on PC-3 cells were decreased. It suggests that AX2 induces apoptosis of PC-3 cells via meddling in the mTOR/PTEN/PI3K/Akt signaling pathway, but those effects are compounded by MiRNA144. Both AX2 and MiRNA144 intercept the signaling in different ways but cross on mTOR.